Meta menu:

From here, you can access the Emergencies page, Contact Us page, Accessibility Settings, Language Selection, and Search page.

Open Menu
Ein Forscher träufelt aus einer kleinen Pipette eine Flüssigkeit in ein Reagenzglas. Mehrere Reagenzgläser und ein Erlenmeyerkolben vorn rechts sind mit einer hellblauen, klaren Flüssigkeit gefüllt. Kopf und Schultern des Forschers sind nur unscharf im Hintergrund zu erkennen.

Research at the Institute of Pharmacology

The research focus of the Institute of Pharmacology is in the area of applied - basic medical research as well as the development of new drugs. We concentrate our work on therapeutic developments for the therapy of cardiovascular disease, metabolic diseases including obesity and diabetes mellitus, and dementia.

You are here:

The research activities of the institute focus on the therapy of chronic heart failure, in particular with accompanying metabolic diseases such as obesity and diabetes. Additionally, we focus on hepatic lipid and glucose metabolism, and the characterization of new therapeutic target molecules in this organ for the treatment of diabetes mellitus. The department of neuro- / molecular pharmacology investigates new therapies for the treatment of dementia.

The research work and organization is largely done in close co-operation with scientific and clinical institutions both at national and international level.

In order to address these topics, we have a broad spectrum of molecular biology, immunological, immunohistochemical, biochemical, analytical and animal experiments in the area of the cardiovascular system, nervous system and metabolic medicine.

Research Funding

Research at the institute is supported by different models of funding. Institutions that supply with third party funding (DFG, BMBF, Industry) are listed within the individual project descriptions. Moreover, the Charité gives decent support for the projects by co-financing them with governmental means for research and education.